Home Pharma News USFDA approves Moderna, J&J vaccine booster shots

USFDA approves Moderna, J&J vaccine booster shots

by Vaishali Sharma

Following unanimous votes by a committee of independent advisors last week, the Food and Drug Administration approved booster doses of the COVID-19 vaccines produced by Moderna and Johnson & Johnson.

In a similar decision, the FDA approved boosters that are not the same as the vaccination used to immunise people against COVID-19. As an example, a person who received a Johnson & Johnson vaccination may obtain a booster from Moderna or Pfizer-BioNTech.

The regulatory changes pave the way for more widespread usage of boosters. The FDA approved a booster dose of the Pfizer COVID-19 vaccine in September.

“The available data suggest waning immunity in some populations who are fully vaccinated,” said the FDA’s acting commissioner, Dr. Janet Woodcock, in a statement. “The availability of these authorized boosters is important for continued protection against COVID-19 disease.”

On Thursday, a committee of advisers to the Centers for Disease Control and Prevention is scheduled to meet to discuss COVID-19 vaccine booster shots and make recommendations on their use. The CDC director makes the final call on vaccine guidelines. After the CDC issues its guidance, the rollout can begin officially.

You may also like